---
title: Dr. Stephen Salloway on Potential of Aducanumab for Alzheimer's Treatment
description: Memory and Aging Program Director Dr. Stephen Salloway shares important insights on the potential impact of aducanumab, if it is approved by the FDA as a treatment for Alzheimer's.
---

[Memory and Aging Blog | Butler Hospital ](https://www.butler.org/memoryandaging)

# [Dr. Stephen Salloway on Potential of Aducanumab for Alzheimer's Treatment](https://www.butler.org/memoryandaging/dr-stephen-salloway-potential-aducanumab-alzheimers-treatment)

 Written by [Laura Dunn](https://www.butler.org/memoryandaging/author/ldunn) | Feb 25, 2021 1:35:00 PM

News from the [Memory and Aging Program at Butler Hospital](https://www.butler.org/memory)

February 25, 2021

 

#### Aducanumab is an investigational drug for the treatment of Alzheimer's, which is currently being reviewed by the FDA.

 

[In this recent Neurology Live article](https://www.neurologylive.com/view/aducanumab-alzheimer-disease-treatment-landscape), Dr. Stephen Salloway, Director of Neurology and of the [Memory and Aging Program at Butler Hospital](https://www.neurologylive.com/view/aducanumab-alzheimer-disease-treatment-landscape) and Professor, [Warren Alpert Medical School of Brown University](https://medical.brown.edu/), shared some important insights on the potential impact of the drug, if it is approved. 

 

> My take is that it would open a new modern treatment era for AD. It would just be the beginning—a stepping stone, rather than the final breakthrough. There was a really good quote the other day, from a colleague of mine, who said, “In order to get the best-in-class drug, we must have the first-in-class drug.” That’s how I see this.

 

 

### Explore More from The Memory and Aging Program at Butler Hospital

 

- [Memory and Aging Program Home](https://www.butler.org/memory)
- [Clinical Trials for Alzheimer's Prevention and Treatment](https://www.butler.org/memory/clinical-trials)
- [Join the Alzheimer's Prevention Registry](https://www.butler.org/memory/alzheimers-prevention-registry)
- [News and Events](https://www.butler.org/memoryandaging)
- [Volunteer](https://www.butler.org/memory/volunteer)
- [Donate](https://www.butler.org/memory/donate)

[View full post](https://www.butler.org/memoryandaging/dr-stephen-salloway-potential-aducanumab-alzheimers-treatment)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Laura Dunn"
  },
  "dateModified" : "2021-04-16T13:32:41.942Z",
  "datePublished" : "2021-02-25T13:35:00Z",
  "headline" : "Dr. Stephen Salloway on Potential of Aducanumab for Alzheimer's Treatment",
  "image" : {
    "@type" : "ImageObject",
    "height" : 209,
    "url" : "https://www.carenewengland.org/hubfs/-%20BUTLER/PET-scan-image_1.jpg",
    "width" : 500
  },
  "mainEntityOfPage" : "https://www.butler.org/memoryandaging/dr-stephen-salloway-potential-aducanumab-alzheimers-treatment",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Memory and Aging Blog"
  }
}
```